AC
AVXL icon

AXQ Capital’s Anavex Life Sciences AVXL Stock Holding History

AXQ Capital’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.1K Sell
11,421
-13,575
-54% -$58.8K ﹤0.01% 949
2025
Q4 		$89K Buy
24,996
+5,895
+31% +$36.1K 0.02% 668
2025
Q3 		$170K Buy
+19,101
New +$194K 0.07% 474
2025
Q2 		– Sell
-17,888
Closed -$153K – 579
2025
Q1 		$153K Buy
+17,888
New +$169K 0.06% 422
2024
Q1 		– Sell
-19,600
Closed -$182K – 620
2023
Q4 		$182K Buy
+19,600
New +$135K 0.05% 544

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

AXQ Capital's AVXL Position: Q1 2026 in Review

AXQ Capital reduced its Anavex Life Sciences (AVXL) stake by 54% in Q1 2026, selling an estimated $58.8K and leaving 11,421 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #949.

AXQ Capital first reported a position in AVXL in Q4 2023 and has held it in 5 quarters since. The position peaked at $182K in Q4 2023. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • AXQ Capital held 11,421 shares of Anavex Life Sciences worth $35.1K as of Q1 2026.
  • AXQ Capital sold 13,575 Anavex Life Sciences shares in Q1 2026, an estimated $58.8K.
  • Anavex Life Sciences made up ﹤0.01% of AXQ Capital's portfolio in Q1 2026, its #949 holding.
  • AXQ Capital first reported a position in Anavex Life Sciences in Q4 2023 and has held it in 5 quarters since.
  • AXQ Capital's Anavex Life Sciences position peaked at $182K in Q4 2023.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.